3-15451691-T-C
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PM2PP2PP5
The NM_005677.4(COLQ):c.1321A>G(p.Thr441Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,613,960 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T441T) has been classified as Likely benign.
Frequency
Consequence
NM_005677.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 5Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COLQ | NM_005677.4 | c.1321A>G | p.Thr441Ala | missense_variant | Exon 17 of 17 | ENST00000383788.10 | NP_005668.2 | |
| COLQ | NM_080538.2 | c.1291A>G | p.Thr431Ala | missense_variant | Exon 17 of 17 | NP_536799.1 | ||
| COLQ | NM_080539.4 | c.1219A>G | p.Thr407Ala | missense_variant | Exon 16 of 16 | NP_536800.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COLQ | ENST00000383788.10 | c.1321A>G | p.Thr441Ala | missense_variant | Exon 17 of 17 | 1 | NM_005677.4 | ENSP00000373298.3 | ||
| COLQ | ENST00000603808.5 | c.1324A>G | p.Thr442Ala | missense_variant | Exon 17 of 17 | 1 | ENSP00000474271.1 | |||
| ENSG00000293553 | ENST00000629729.3 | n.*45A>G | non_coding_transcript_exon_variant | Exon 3 of 6 | 5 | ENSP00000518887.1 | ||||
| ENSG00000293553 | ENST00000629729.3 | n.*45A>G | 3_prime_UTR_variant | Exon 3 of 6 | 5 | ENSP00000518887.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152132Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 251198 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461828Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727220 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152132Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74316 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 5 Pathogenic:4
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COLQ protein function. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 447217). This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 441 of the COLQ protein (p.Thr441Ala). This variant is present in population databases (rs375215281, gnomAD 0.006%). This missense change has been observed in individuals with congenital myasthenic syndrome (PMID: 15248101, 18180250, 22678886). It has also been observed to segregate with disease in related individuals.
not provided Pathogenic:1Uncertain:1
Reported with a second COLQ variant, phase unknown, in a patient with ptosis, pain, and muscle weakness (Wargon et al., 2012); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 31773638, 32528171, 18180250, 34553317, 15248101, 22088788)
COLQ-related disorder Pathogenic:1
The COLQ c.1321A>G variant is predicted to result in the amino acid substitution p.Thr441Ala. This variant has been reported to be causative for myasthenic syndrome (Muller et al 2004. PubMed ID: 15248101; Mihaylova et al. 2008 PubMed ID: 18180250; Tables S2a & S2b, Abicht et al. 2012. PubMed ID: 22678886). This variant is reported in 0.0054% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at